Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes
达格列净治疗与人类 2 型糖尿病患者心外膜脂肪组织厚度和心外膜葡萄糖摄取量的减少有关。
期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-023-02091-0
Cinti, Francesca; Leccisotti, Lucia; Sorice, Gian Pio; Capece, Umberto; D'Amario, Domenico; Lorusso, Margherita; Gugliandolo, Shawn; Morciano, Cassandra; Guarneri, Andrea; Guzzardi, Maria Angela; Mezza, Teresa; Capotosti, Amedeo; Indovina, Luca; Ferraro, Pietro Manuel; Iozzo, Patricia; Crea, Filippo; Giordano, Alessandro; Giaccari, Andrea